Search Results - zaver+bhujwalla

4 Results Sort By:
Diagnostics and Therapeutic Monitoring Using AI Analysis Integrated with Magnetic Resonance Spectral Patterns of Biofluids
Unmet needPancreatic ductal adenocarcinoma (PDAC) is the most frequent form of pancreatic cancer, with a survival rate of less than 10% at five years largely due to late-stage diagnosis1. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, which is the leading cause of cancer death worldwide, primarily due to metastatic disease2....
Published: 6/28/2024   |   Inventor(s): Meiyappan Solaiyappan, Santosh Bharti, Zaver Bhujwalla, Michael Goggins, Malcolm Brock
Keywords(s):  
Category(s): Technology Classifications > Diagnostics
A Novel Method to Efficiently Synthesize a Biodegradable Dextran to Use as an Efficient Cationic Nanopolymer Carrier for siRNA Delivery
Unmet NeedIn theory, RNA interference (RNAi) can be used to decrease expression of any gene driving a disease or pathology, but has seen limited clinical usage as gene therapy due to technical issues, i.e., small interfering RNA (siRNA) cannot enter cells efficiently due to their weight and charge. As such, a carrier molecule is needed to bring siRNA...
Published: 6/27/2024   |   Inventor(s): Zaver Bhujwalla, Zhihang Chen
Keywords(s): Biologics, Cancers, Disease Indication, Drug Delivery Vehicle, Nucleic Acid, Polymers, Therapeutic Matter, Therapeutic Method, Therapeutic Substance, Therapeutics
Category(s): Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms, Technology Classifications > Therapeutic Modalities > Dendrimers & Polymers, Technology Classifications > Research Tools > Nucleic Acids
PSMA-based Theranostic Imaging of Metastatic Cancer
C11482: PSMA-based Theranostic Imaging of Metastatic CancerNovelty: This invention is a pharmaceutical composition and method for the effective imaging, targeting, and treatment of metastatic tumor cells.Value Proposition: In the United States, prostate cancer (PCa) is the second leading cause of cancer-related death among men. There is a compelling...
Published: 6/27/2024   |   Inventor(s): Zhihang Chen, Cong Li, Sridhar Nimmagadda, Zaver Bhujwalla, Sangeeta Ray, Marie-France Penet, Martin Pomper
Keywords(s): Cancers, Disease Indication, Drug Delivery Vehicle, Imaging Agent, Imaging and Sensing Systems, In Vivo Medical Imaging, Nanoparticles, Prostate Cancer, Therapeutic Matter, Therapeutics
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Men's Health, Clinical and Disease Specializations > Oncology > Prostate Cancer, Technology Classifications > Medical Devices > Imaging, Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms, Technology Classifications > Medical Devices, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities
Self-Assembled, Micropatterned, and Radio Frequency (RF) Shielded BioContainers
C04751: Self-Assembled, Micropatterned, and Radio Frequency (RF) Shielded BioContainersValue Proposition: • This is the first demonstration of a three dimensional (3D) micropatterned, metallic container capable of encapsulating microbeads and cells. • The 3D containers can be patterned into almost any shape using conventional micro fabrication...
Published: 6/27/2024   |   Inventor(s): Zaver Bhujwalla, Barjor Gimi, David Gracias
Keywords(s): Imaging and Sensing Systems, In Vivo Medical Imaging, Industrial Manufacturing, Manufactured Devices
Category(s): Technology Classifications > Industrial Tech > Industrial Manufacturing, Technology Classifications > Industrial Tech, Technology Classifications > Medical Devices > Imaging, Technology Classifications > Engineering Tech > Industrial Manufacturing
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum